Topic

peptide therapy

8 articles on peptide therapy in longevity medicine. View all news →

FDA: EGRIFTA WR Prescribing Information

Tesamorelin in Longevity Clinics: FDA-Approved Peptide or Off-Label Hype?

Tesamorelin has an FDA-approved HIV lipodystrophy indication, but not for longevity, ordinary weight loss, cognition, bodybuilding, or anti-aging.

PRNewswire: UFC GYM, NexGen MD Scientific launch PWR Clinics

UFC GYM PWR Clinics: Longevity Medicine Inside Fitness Clubs

A buyer guide to UFC GYM's PWR Clinics announcement, gym-based longevity medicine, and what to verify before buying GLP-1, TRT, peptide, IV, or recovery programs.

Victoria Department of Health retatrutide health alert

Retatrutide Safety Alert: What Longevity Clinic Buyers Should Know About Unapproved Peptides

Retatrutide is promising in obesity trials, but products sold as retatrutide outside trials have triggered liver-toxicity warnings. Here is how clinic buyers can separate legitimate care from grey-market peptide risk.

The Guardian: Medicines watchdog to investigate UK peptide clinics over health claims

Are Longevity Clinics Regulated? What UK, EU, US, and Swiss Patients Should Know in 2026

Longevity clinics are usually regulated through doctors, medicines, devices, diagnostics, premises, and advertising claims — not as one universal clinic category.

longevity clinic regulation patient safety peptide therapy
FDA: July 2026 Pharmacy Compounding Advisory Committee meeting

Peptide Therapy at Longevity Clinics: FDA Status and Safety Questions (2026)

What the FDA's July meeting did and did not change for BPC-157, TB-500, MOTS-c, Semax, Epitalon and other peptides marketed by longevity clinics.

FDA: July 2026 Pharmacy Compounding Advisory Committee meeting

Peptide Therapy at Longevity Clinics: Why WLC Withdrew Its 2026 Ranking

WLC withdrew its 2026 peptide-clinic ranking because provider flags, marketing sources, dose tables, prices, and a claimed FDA reclassification did not support a safe recommendation.

NPR: The government may soon lift restrictions on some peptide treatments

FDA Peptide Reclassification 2026: Announcement vs Final Action

An HHS announcement prompted reports of a peptide reclassification. Later FDA records show why an announcement, compounding policy, drug approval, and clinical evidence are different questions.

Longevity Docs newsletter

'Back to Medicine' at Longevity Docs Cannes: A Peptide Traceability Checklist

Longevity Docs promotes evidence, supervision, and traceable peptide supply. FDA records show why patients and clinics must verify the ingredient, compounder, lot, and regulatory pathway.